Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon

India’s health minister says the Serum Institute of India and Bharat Biotech are expected to pursue Phase III trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, as reported in Fidelity.

Meanwhile, the Indian Council of Medical Research said it will revisit its protocol for COVID-19 treatment after a World Health Organization trial found some of the commonly used drugs, including remdesivir, had little or no impact on survival among hospitalized patients.

By Fidelity via NewsPoints Desk
Read the original article